Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
about
Polypoidal Choroidal Vasculopathy in AsiansManagement of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.Chorioretinal ischemia and angiogenic milieu following photodynamic therapy.Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: short-term resultsOscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.A comparative analysis of C57BL/6J and 6N substrains; chemokine/cytokine expression and susceptibility to laser-induced choroidal neovascularization.Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranesMatrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.Vascular endothelial growth factor in eye disease.Treatment of age-related macular degeneration: focus on ranibizumabThe significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration.Review of combination therapies for neovascular age-related macular degeneration.Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro.Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinoloneEffect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation.Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.Towards a rational approach to combination therapy for neovascular age-related macular degeneration.Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.Polypoidal Choroidal Vasculopathy.
P2860
Q26799548-7E7C5AE7-BA33-40C1-9D88-2652CF23F8E3Q30249206-7EC6E11A-B4EC-436F-A78C-A21F7884444EQ30980461-A6DAAEC5-8798-4E3F-AA80-6BF094CAF7DFQ34007126-95740D68-9353-40BB-9EED-1B90C70FEFD8Q34210541-879B4833-B16B-45DF-ADD2-C9ED72FDF7D7Q35322953-12C262BF-4B7A-4E6B-BAA2-43FC56171557Q35762984-F69BA8E1-D588-4C25-B7EA-F0D1B1C9683FQ35954001-26A078D7-6304-4464-A0C2-3F2B7F720854Q36172252-522C38D2-C02A-474B-B03C-811D39743526Q36788529-1A0C3A3B-C857-4542-9C6F-BD509FC593C2Q36929380-FDA038E9-A557-4E8A-99A6-8FB33BA016E7Q37233230-847E6A2F-A646-42C4-BF58-8E210DF682CBQ37247435-87EFEBE8-D12E-4B88-AFEC-21EABE59A33FQ37406558-386A0DFE-EFD6-4D31-AD32-B07BA5544A15Q37879161-10A53D68-D994-4592-BBFB-8BE3F77247CBQ37882685-6E744475-9F6C-464E-BD5E-2797FEBBD415Q40229459-3A393604-9D18-41E6-BA1B-F1DA5E58DBE6Q41102960-5D5B35A7-3E0B-4A01-818A-374CC0D9E6EFQ41350550-90AD0CB6-C91B-4C2C-B353-ED89BB27642BQ41588049-B07BEED8-DB6D-4420-A2B9-AB8FE346982DQ41788258-77C7D2ED-FB90-4415-9E96-AD369CCBD3E0Q42840743-803EE7AE-131F-47BF-88BB-26903829DD3FQ48095945-29B70187-F2E4-442A-A456-A136077A22A0Q50482167-98A6F03A-8A08-4634-8449-D7A339DA04C0Q55714679-F4804AC1-0A15-430B-9671-CD58B5FB9758
P2860
Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@ast
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@en
type
label
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@ast
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@en
prefLabel
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@ast
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@en
P2093
P1476
Expression of VEGF and PEDF in ...... teporfin photodynamic therapy.
@en
P2093
Annemarie Adam
Claus Eckardt
Kei Shinoda
Matthias Lüke
Olcay Tatar
Peter Stalmans
Salvatore Grisanti
P304
P356
10.1016/J.AJO.2006.01.085
P407
P577
2006-07-01T00:00:00Z